ADRB2 and breast cancer: In addition to the impact of β2-AR signaling pathway on CD8+T cells, our group showed that chronic stress acting via β2-receptor signaling results in promotion of proliferation and survival of myeloid derived suppressor cells (MDSC) in a murine breast cancer model [46], leading to suppression of antitumor immune response.